Healthcare provider profile · identity verified

Salman Rahman, M.D.

Internal Medicine · MIDDLEBURG HEIGHTS, OH · NPI 1023259744

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	330	88
Levothyroxine Sodium	Levothyroxine Sodium	243	55
Omeprazole	Omeprazole	224	47
Furosemide	Furosemide	216	63
Amlodipine Besylate	Amlodipine Besylate	215	46
Gabapentin	Gabapentin	195	47
Albuterol Sulfate Hfa	Albuterol Sulfate	175	41
Lisinopril	Lisinopril	158	35
Metoprolol Succinate	Metoprolol Succinate	150	38
Losartan Potassium	Losartan Potassium	147	31
Metformin Hcl	Metformin Hcl	142	33
Potassium Chloride	Potassium Chloride	134	41
Eliquis	Apixaban	117	26
Simvastatin	Simvastatin	112	21
Pantoprazole Sodium	Pantoprazole Sodium	110	30
Tramadol Hcl	Tramadol Hcl	103	36
Duloxetine Hcl	Duloxetine Hcl	91	23
Sertraline Hcl	Sertraline Hcl	88	29
Metoprolol Tartrate	Metoprolol Tartrate	83	21
Tamsulosin Hcl	Tamsulosin Hcl	80	18
Jardiance	Empagliflozin	75	19
Trazodone Hcl	Trazodone Hcl	68	23
Rosuvastatin Calcium	Rosuvastatin Calcium	67	16
Nystatin	Nystatin	64	23
Fluticasone Propionate	Fluticasone Propionate	58	17
Hydrochlorothiazide	Hydrochlorothiazide	58	15
Warfarin Sodium	Warfarin Sodium	58	11
Hydralazine Hcl	Hydralazine Hcl	55	suppressed
Lorazepam	Lorazepam	55	19
Ciprofloxacin Hcl	Ciprofloxacin Hcl	54	39
Clopidogrel	Clopidogrel Bisulfate	54	12
Carvedilol	Carvedilol	53	15
Mirtazapine	Mirtazapine	53	14
Glipizide	Glipizide	52	suppressed
Buspirone Hcl	Buspirone Hcl	51	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	50	14
Escitalopram Oxalate	Escitalopram Oxalate	49	12
Allopurinol	Allopurinol	48	suppressed
Montelukast Sodium	Montelukast Sodium	48	16
Citalopram Hbr	Citalopram Hydrobromide	46	11
Atenolol	Atenolol	45	suppressed
Donepezil Hcl	Donepezil Hcl	45	18
Baclofen	Baclofen	43	14
Nifedipine Er	Nifedipine	41	suppressed
Januvia	Sitagliptin Phosphate	39	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	38	suppressed
Torsemide	Torsemide	35	suppressed
Azithromycin	Azithromycin	34	30
Methimazole	Methimazole	34	suppressed
Alendronate Sodium	Alendronate Sodium	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	33	suppressed
Glimepiride	Glimepiride	33	suppressed
Ozempic	Semaglutide	33	suppressed
Topiramate	Topiramate	33	suppressed
Alprazolam	Alprazolam	32	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	12
Doxycycline Hyclate	Doxycycline Hyclate	30	24
Hydroxyzine Hcl	Hydroxyzine Hcl	30	suppressed
Labetalol Hcl	Labetalol Hcl	29	suppressed
Levetiracetam	Levetiracetam	29	suppressed
Memantine Hcl	Memantine Hcl	28	suppressed
Pregabalin	Pregabalin	28	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Meloxicam	Meloxicam	27	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	27	suppressed
Finasteride	Finasteride	26	suppressed
Spironolactone	Spironolactone	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	25	suppressed
Methylprednisolone	Methylprednisolone	24	22
Sotalol	Sotalol Hcl	24	suppressed
Nyamyc	Nystatin	22	suppressed
Ondansetron Hcl	Ondansetron Hcl	22	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Calcium Acetate	Calcium Acetate	21	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	21	suppressed
Fluconazole	Fluconazole	21	12
Humalog Kwikpen U-100	Insulin Lispro	21	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	14
Paroxetine Hcl	Paroxetine Hcl	21	suppressed
Xarelto	Rivaroxaban	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Prednisone	Prednisone	20	11
Digoxin	Digoxin	19	suppressed
Glipizide Er	Glipizide	19	suppressed
Mupirocin	Mupirocin	19	14
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Clonidine Hcl	Clonidine Hcl	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Oxycodone Hcl	Oxycodone Hcl	18	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	18	11
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	18	suppressed
Divalproex Sodium	Divalproex Sodium	17	suppressed
Nystop	Nystatin	17	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	16	suppressed
Famotidine	Famotidine	16	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	15	suppressed
Lamotrigine	Lamotrigine	15	suppressed
Latanoprost	Latanoprost	15	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	14	suppressed
Levofloxacin	Levofloxacin	14	14
Meclizine Hcl	Meclizine Hcl	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	14	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	13	suppressed
Diazepam	Diazepam	13	suppressed
Incruse Ellipta	Umeclidinium Bromide	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Estradiol	Estradiol	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Trijardy Xr	Empaglifloz/Linaglip/Metformin	12	suppressed
Insulin Syringe	Syring-Needl,disp,insul,0.3 Ml	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error